发布求助
文献互助 智能选刊 最新文献

Drugs of The Future最新文献

筛选
英文 中文
Ancremonam. Monobactam, Treatment of multidrug-resistant Enterobacteriaceae infections Ancremonam。单巴坦，治疗多重耐药肠杆菌科感染
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2023-01-01 DOI: 10.1358/dof.2023.48.2.3400571
M. Ahmad, A. Dasgupta, S. Chopra
{"title":"Ancremonam. Monobactam, Treatment of multidrug-resistant Enterobacteriaceae infections","authors":"M. Ahmad, A. Dasgupta, S. Chopra","doi":"10.1358/dof.2023.48.2.3400571","DOIUrl":"https://doi.org/10.1358/dof.2023.48.2.3400571","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Society for Immunotherapy of Cancer (SITC) - 37th Annual Meeting. Boston/Virtual - November 8-12, 2022 癌症免疫治疗学会(SITC)第37届年会。波士顿/Virtual - 2022年11月8日至12日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2023-01-01 DOI: 10.1358/dof.2023.48.2.3542401
J. Toldrà
{"title":"Society for Immunotherapy of Cancer (SITC) - 37th Annual Meeting. Boston/Virtual - November 8-12, 2022","authors":"J. Toldrà","doi":"10.1358/dof.2023.48.2.3542401","DOIUrl":"https://doi.org/10.1358/dof.2023.48.2.3542401","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovative new pharma and biotech partnerships: How is the landscape transforming? Highlights from the Society for Medicines Research Conference. Stevenage - July 7, 2022 创新的新型制药和生物技术合作伙伴关系:格局如何转变?来自医学研究学会会议的亮点。斯蒂夫尼奇——2022年7月7日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2023-01-01 DOI: 10.1358/dof.2023.48.2.3542442
M. Alavijeh, D. Black, G. Macdonald
{"title":"Innovative new pharma and biotech partnerships: How is the landscape transforming? Highlights from the Society for Medicines Research Conference. Stevenage - July 7, 2022","authors":"M. Alavijeh, D. Black, G. Macdonald","doi":"10.1358/dof.2023.48.2.3542442","DOIUrl":"https://doi.org/10.1358/dof.2023.48.2.3542442","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66447040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pipeline on the Move - June 2022 管道在移动- 2022年6月
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.6.3444838
L. Fernández Bertolín
{"title":"Pipeline on the Move - June 2022","authors":"L. Fernández Bertolín","doi":"10.1358/dof.2022.47.6.3444838","DOIUrl":"https://doi.org/10.1358/dof.2022.47.6.3444838","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RGX-314. AAV8 gene therapy encoding anti-VEGF Fab, Treatment of wet age-related macular degeneration, Treatment of diabetic retinopathy rgx - 314。编码抗vegf Fab的AAV8基因治疗，湿性老年性黄斑变性的治疗，糖尿病视网膜病变的治疗
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.10.3447918
L. Ferro Desideri, S. Vaccaro, A. Vagge, M. Nicolò, V. Scorcia, C. Traverso, G. Giannaccare
{"title":"RGX-314. AAV8 gene therapy encoding anti-VEGF Fab, Treatment of wet age-related macular degeneration, \u0000Treatment of diabetic retinopathy","authors":"L. Ferro Desideri, S. Vaccaro, A. Vagge, M. Nicolò, V. Scorcia, C. Traverso, G. Giannaccare","doi":"10.1358/dof.2022.47.10.3447918","DOIUrl":"https://doi.org/10.1358/dof.2022.47.10.3447918","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66440604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pelacarsen. Antisense oligonucleotide targeting apolipoprotein(a), Treatment of lipoprotein disorders, Treatment of cardiovascular diseases Pelacarsen。靶向载脂蛋白的反义寡核苷酸(a)，脂蛋白紊乱的治疗，心血管疾病的治疗
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.1.3369190
B. Warden, P. Duell
{"title":"Pelacarsen. Antisense oligonucleotide targeting apolipoprotein(a), Treatment of lipoprotein disorders, Treatment of cardiovascular diseases","authors":"B. Warden, P. Duell","doi":"10.1358/dof.2022.47.1.3369190","DOIUrl":"https://doi.org/10.1358/dof.2022.47.1.3369190","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66440872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An overview of prophylaxis and treatment indications for COVID-19-related thrombotic complications. Review of the recent literature covid -19相关血栓性并发症的预防和治疗指征概述回顾最近的文献
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.11.3435134
A. Moreno-Castaño, G. Escolar, M. Díaz-Ricart
{"title":"An overview of prophylaxis and treatment indications for COVID-19-related thrombotic complications. Review of the recent literature","authors":"A. Moreno-Castaño, G. Escolar, M. Díaz-Ricart","doi":"10.1358/dof.2022.47.11.3435134","DOIUrl":"https://doi.org/10.1358/dof.2022.47.11.3435134","url":null,"abstract":"In 2020, a coronavirus-related disease (COVID-19) became a pandemic. The disease was recognized as a viral respiratory illness caused by SARS-CoV-2. Histologic analysis of pulmonary vessels in severely affected patients revealed a microangio-pathic thrombosis. It was rapidly recognized that the disease could behave as a thrombotic disease, both in the venous and arterial circulations and affecting multiple organs. Anticoa-gulant treatments were immediately considered to prevent or control the underlying coagulopathy. The emergency of the situation and the limited knowledge in the early months accounted for variable success of the anticoagulation regi-mens. The benefit/bleeding risk ratio of anticoagulant treat-ments depended on the severity and evolution of the disease in different subgroups of patients. This review aims to provide a synthesized guide on how anticoagulant protocols indicated for the prophylaxis and treatment of COVID-19-related hyper -coagulable state have evolved and have been successfully adapted to specific scenarios throughout the pandemic.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66440996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Xeruborbactam. Ultrabroad-spectrum beta-lactamase inhibitor, Treatment of bacterial infections Xeruborbactam。超广谱β -内酰胺酶抑制剂，治疗细菌感染
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.11.3400746
D. Saxena, A. Dasgupta, S. Chopra
{"title":"Xeruborbactam. Ultrabroad-spectrum beta-lactamase inhibitor, Treatment of bacterial infections","authors":"D. Saxena, A. Dasgupta, S. Chopra","doi":"10.1358/dof.2022.47.11.3400746","DOIUrl":"https://doi.org/10.1358/dof.2022.47.11.3400746","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66441369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
European Respiratory Society - 32nd International Congress. Barcelona - September 4-6, 2022 欧洲呼吸学会第32届国际大会。巴塞罗那——2022年9月4日至6日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.11.3500031
A. Al-Shamahi
{"title":"European Respiratory Society - 32nd International Congress. Barcelona - September 4-6, 2022","authors":"A. Al-Shamahi","doi":"10.1358/dof.2022.47.11.3500031","DOIUrl":"https://doi.org/10.1358/dof.2022.47.11.3500031","url":null,"abstract":"The 32nd European Respiratory Society (ERS) International Congress was held again in person at the FIRA Barcelona Gran Via Conference Center in Spain, as well as online. On-site attendance was limited to 10,000 delegates, with the spaces selling out before the conference began. The program included live streamed presentations, thematic poster discussion sessions, oral presentations, mini-symposia, industry exhibitors and skills workshops to discuss major respiratory fields that included thoracic oncology, respiratory infections, interstitial lung diseases, respiratory critical care, sleep and breathing disorders and pulmonary vascular diseases. This report will cover some of the most interesting presentations related to respiratory disease treatment. Copyright © 2022 Clarivate.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"32 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66441511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 40th Annual J.P. Morgan Healthcare Conference. Virtual - January 10-13, 2022 第40届摩根大通医疗保健年会。虚拟——2022年1月10日至13日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.4.3422311
P. Sudha, J. Polychrones, D. Komlos
{"title":"The 40th Annual J.P. Morgan Healthcare Conference. Virtual - January 10-13, 2022","authors":"P. Sudha, J. Polychrones, D. Komlos","doi":"10.1358/dof.2022.47.4.3422311","DOIUrl":"https://doi.org/10.1358/dof.2022.47.4.3422311","url":null,"abstract":"The 40th Annual J.P. Morgan Healthcare Conference was conducted as a virtual conference for the second consecutive year due to the COVID-19 pandemic. Being the largest investment symposium in the healthcare industry, the conference brought together thousands of investors around the globe and hundreds of companies from the whole global healthcare landscape, that includes pharmaceutical companies, medical device firms, healthcare service providers, and profit and not-for-profit organizations. This report covers a selection of company presentations given over the duration of the conference. Copyright © 2022 Clarivate","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信